Live WebinarEssentials for Igniting Evidence-Based Practice
01 Dec 2020, 08:00 PM EST (New York)
Joanna Asadoorian PhD, RDH
November 02, 2020 | Advertorial
BORDEAUX, France: Tooth extraction is the most common procedure performed in oral surgery.1 For example, ten million third molars are removed each year in the US alone, according to the American Public Health Association.2 Dentists are ethically committed to using the least traumatic surgical options and least invasive techniques in order to ensure patients’ well-being, thus less traumatic extraction and implant placement are becoming the norm in today’s implant surgery.
June 22, 2020 | Business
BORDEAUX, France: Michael Rynerson is the new CEO of the dental and medical technology and device manufacturer ACTEON, which is headquartered in France. The supervisory board of Finapolline, the holding company of ACTEON, appointed him to the position effective on 1 June. The chairman of the supervisory board commented that Rynerson has over 25 years of experience, most notably in the dental industry, and possesses the skills to lead the company out of the current health and economic crisis and through its next phase of development.
February 21, 2020 | Advertorial
CHICAGO, U.S.: Few products have had such a positive effect on dentistry as the EXPASYL gingival retraction paste from ACTEON. After 20 years of clinical research and efficacy, EXPASYL continues to be the choice of many dentists for tissue management during restorative and cosmetic dental treatment. Now, EXPASYL EXACT is available on the market. It offers the same results in the exact amount needed in a cost-effective, single-use capsule that can be used in any composite gun. This means that there will be no more wasted material and there is no need to purchase expensive application guns. At the 155th Chicago Dental Society Midwinter Meeting currently being held in Chicago, interested parties can view the new product at the ACTEON booth (#2811).
February 03, 2020 | Advertorial
DUBAI, UAE: The innovation offered by X-MIND trium and X-MIND prime confirms ACTEON as a leader in designing less invasive, less traumatic and the most technologically advanced dental imaging solutions. The company is showcasing both devices at AEEDC 2020 and invites participants to learn more at the ACTEON booth (#6 G01).
September 26, 2019 | Advertorial
LISBON, Portugal: X-Mind prime is the latest addition to ACTEON’s CBCT digital imaging product line. It blends cutting-edge technology with ease of use in a compact design. With X-Mind prime 3D, high tech is at your fingertips with tools for accurate diagnosis and complete treatment planning. It is a lightweight and compact system that can fit into any dental office. ACTEON is showcasing its new product at the 28th Annual Scientific Meeting of the European Association for Osseointegration (EAO 2019), currently being held in Lisbon.
August 26, 2019 | Advertorial
Acteon präsentiert mit dem Pietzotome Cube Star die Weiterentwicklung seines Knochen-Ultraschallchirurgiegeräts auf der IDS. Mit dem neuen Pietzotome Cube Star gebe es weniger Schmerzen und weniger Blutungen, verspricht Laurent Zenou, Product Direktor Imaging bei Acteon. Implantologe Prof. Dr. Marcel Wainwright nennt das neue Gerät ein „Worldclass Tool“. Ebenfalls neu sind die 3-D Röntgengerät X-Mind prime und X-Mind trium.
March 29, 2019 | News
COLOGNE, Germany: At the 2019 International Dental Show (IDS), French company ACTEON released the latest addition to its 2 D and CBCT panoramic product line, the X-Mind prime. Mixing cutting-edge technology with enhanced simplicity, the new scanner generated a great deal of interest from attendees of IDS.
March 14, 2019 | News
COLOGNE, Germany: France-based company ACTEON earlier this week released its latest surgical device, Piezotome Cube STAR. Providing full preservation of crestal bone with a surgery duration comparable to that of rotary instruments and combining two patented technologies, NEWTRON and D.P.S.I., the new piezo-surgery device developed by ACTEON engineers’ clinical application team allows practitioners to drill safely into the bone and offers many other features.
March 13, 2019 | Advertorial
COLOGNE, Germany: Piezotome Cube STAR is a new piezo-surgery device manufactured by ACTEON. Being introduced at IDS 2019, Piezotome Cube STAR provides full preservation of the crestal bone with a surgery duration comparable to that of rotary instruments. Combining two patented technologies, Newtron and D.P.S.I., the new handpiece developed by ACTEON engineers allows practitioners to drill safely into the bone. Once again, ACTEON demonstrates its capacity for innovation and expertise in developing products that become the gold standard for dental surgery.